Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

ABR-238901

Catalog No.
BA6287
Add to Compare
ABR-238901 is an orally effective blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE (Receptor for Advanced Glycosylation End Products) and TLR4 (toll-like receptor 4).
Grouped product items
SizePriceStock Qty
1mL(10 mM in DMSO)
$316.00
Ship with 10-15 days
1mg
$112.00
Ship with 10-15 days
5mg
$288.00
Ship with 10-15 days
10mg
$442.00
Ship with 10-15 days
25mg
$722.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

ABR-238901 is an orally effective blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE (Receptor for Advanced Glycosylation End Products) and TLR4 (toll-like receptor 4).ABR-238901 has the potential to be used in myocardial infarction (MI) studies.

Chemical Properties

Physical AppearanceA solid
Storage-20°C
M.Wt394.63
Cas No.1638200-22-2
FormulaC11H9BrClN3O4S
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.